LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis / C. Xu ... [et al.]. -- ilustr., grafy, tab. -- Bibliogr. odkazy - Res. angl.

In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2020. -- s. 715-945. -- ISSN 0028-2685. -- Vol. 67, no. 4 (2020), s. 782-793

1. nádory vaječníkov 2. RNA dlhá nekódujúca 3. Smad3 proteín 4. mikroRNA 5. bunky nádorové kultivované

I. Xu, C.
II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 67, no. 4 (2020), s. 782-793

lncRNA CDKN2B-AS1 (cyclin-dependent kinase inhibitor 2B antisense RNA1) - miRNA-143-3p - štúdia experimentálna